Anti-IDI1 + IDI2 antibody [EPR17213]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal IDI1 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
Isopentenyl-diphosphate Delta-isomerase 1, Isopentenyl pyrophosphate isomerase 1, IPP isomerase 1, IPPI1, IDI1
- WB
Unknown
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (AB205617)
Blocking and diluting buffer was 5% NFDM /TBST.
All lanes:
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (ab205617) at 1/5000 dilution
All lanes:
Human fetal liver tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 26 kDa
Observed band size: 26 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (AB205617)
Blocking and diluting buffer was 5% NFDM /TBST
All lanes:
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (ab205617) at 1/1000 dilution
Lane 1:
Human fetal kidney lysate at 10 µg
Lane 2:
Human fetal skeletal muscle lysate at 10 µg
Lane 3:
Human colon cancer lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 26 kDa
Observed band size: 26 kDa
true
Exposure time: 3min
- WB
Unknown
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (AB205617)
Blocking and diluting buffer was 5% NFDM /TBST.
All lanes:
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (ab205617) at 1/5000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with IDI1 peptide
Lane 3:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with IDI2 peptide
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 26 kDa
Observed band size: 26 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (AB205617)
Blocking and diluting buffer was 5% NFDM /TBST
Exposure time Lane 1 and 2 : 2minutes;
Lane 3 : 3minutes
All lanes:
Western blot - Anti-IDI1 + IDI2 antibody [EPR17213] (ab205617) at 1/5000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 3:
MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 26 kDa
Observed band size: 26 kDa
true
Exposure time: 2min
Related conjugates and formulations (1)
-
Anti-IDI1+IDI2 antibody [EPR17213] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IDI1 and IDI2 contribute to the regulation of cholesterol and other sterol biosynthesis by converting linear five-carbon units into branched forms necessary for further pathway reactions. Although not usually part of a larger complex these enzymes directly impact the supply of precursors for the synthesis of essential biomolecules such as steroids dolichols and ubiquinones. This transformation is not only pivotal for maintaining lipid homeostasis but also for facilitating cellular proliferation and differentiation.
Pathways
IDI1 and IDI2 should be considered during discussions on the mevalonate pathway which is an important component of cholesterol synthesis and other essential biomolecule formation pathways. These enzymes interact with other proteins involved in the mevalonate pathway including HMG-CoA reductase which functions upstream of IPP and DMAPP isomerization. IDI1 and IDI2 function vitally to ensure a balance between IPP and DMAPP affecting the synthesis rates of downstream isoprenoids and sterols essential for cell membrane structure and signaling.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Molecular biomedicine 6:78 PubMed41071519
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:704 PubMed39349433
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) :e2204711 PubMed36307901
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com